MORPHINE SULFATE 5 mg/1 mL MEDSURGE morphine sulfate pentahydrate 5 mg/1 mL solution for injection ampoule

দেশ: অস্ট্রেলিয়া

ভাষা: ইংরেজি

সূত্র: Department of Health (Therapeutic Goods Administration)

সক্রিয় উপাদান:

morphine sulfate pentahydrate, Quantity: 5 mg

থেকে পাওয়া:

Medsurge Pharma Pty Ltd

ফার্মাসিউটিকাল ফর্ম:

Injection, solution

রচনা:

Excipient Ingredients: water for injections; sodium chloride; hydrochloric acid

প্রশাসন রুট:

Intramuscular, Intravenous, Subcutaneous

প্যাকেজ ইউনিট:

5 x 5 mg/1 mL ampoules

প্রেসক্রিপশন টাইপ:

(S8) Controlled Drug

থেরাপিউটিক ইঙ্গিত:

For the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. May also be used as a pre-operative medication and as an analgesic adjunct in general anaesthesia.

পণ্য সারাংশ:

Visual Identification: Clear colourless to slightly yellow solution; Container Type: Ampoule; Container Material: Glass Type I Coloured; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

অনুমোদন অবস্থা:

Registered

অনুমোদন তারিখ:

2019-07-09

তথ্য লিফলেট

CMI EDITION 3.0 DECEMBER 2020
1
MORPHINE SULFATE
_MORPHINE SULFATE PENTAHYDRATE _
CONSUMER MEDICINE INFORMATION
WARNING
LIMITATIONS OF USE
Morphine Sulfate injection should only be used when your doctor
decides that other treatment options are not able to
effectively manage your pain or you cannot tolerate them.
HAZARDOUS AND HARMFUL USE
Morphine Sulfate injection poses risks of abuse, misuse and addiction
which can lead to overdose and death. Your doctor will
monitor you regularly during treatment.
LIFE THREATENING RESPIRATORY DEPRESSION
Morphine Sulfate injection can cause life-threatening or fatal
breathing problems (slow, shallow, unusual or no breathing) even
when used as recommended. These problems can occur at any time during
use, but the risk is higher when first starting
morphine sulfate and after a dose increase, if you are older, or have
an existing problem with your lungs. Your doctor will
monitor you and change the dose as appropriate.
USE OF OTHER MEDICINES WHILE USING MORPHINE
Using morphine sulfate with other medicines that can make you feel
drowsy such as sleeping tablets (e.g. benzodiazepines),
other pain relievers, antihistamines, antidepressants, antipsychotics,
gabapentinoids (e.g. gabapentin and pregabalin), cannabis
and alcohol may result in severe drowsiness, decreased awareness,
breathing problems, coma and death. Your doctor will
minimise the dose and duration of use; and monitor you for signs and
symptoms of breathing difficulties and sedation. You
must not drink alcohol while using morphine.
WHAT IS IN THIS LEAFLET
This
leaflet
answers
some
common
questions
about
Morphine
Sulfate
injection.
It does not contain all the available
information.
It does not take the place of talking to
your doctor or pharmacist.
The information in this leaflet was last
updated on the date listed on the final
page. More recent information on the
medicine may be available.
YOU SHOULD ENSURE THAT YOU SPEAK TO
YOUR PHARMACIST OR DOCTOR TO OBTAIN
THE MOST UP-TO-DATE INFORMATION ON
THE MEDICINE.
Those updates may

পণ্য বৈশিষ্ট্য

MORPHINE SULFATE INJECTION
_ _
PRODUCT INFORMATION
Edition 4.0 May 2022
Page
1
of
23
AUSTRALIAN PRODUCT INFORMATION
MORPHINE SULFATE MEDSURGE
(MORPHINE SULFATE PENTAHYDRATE)
SOLUTION FOR INJECTION
WARNINGS
LIMITATIONS OF USE
Because of the risks associated with the use of opioids, Morphine
Sulfate injection should only be used in
patients for whom other treatment options, including non-opioid
analgesics, are ineffective, not tolerated
or
otherwise
inadequate
to
provide
appropriate
management
of
pain
(see
section
4.4
SPECIAL
WARNINGS AND PRECAUTIONS FOR USE).
HAZARDOUS AND HARMFUL USE
Morphine Sulfate injection poses risks of hazardous and harmful use
which can lead to overdose and
death. Assess the patient’s risk of hazardous and harmful use before
prescribing and monitor the patient
regularly during treatment (see section 4.4 SPECIAL WARNINGS AND
PRECAUTIONS FOR USE).
LIFE THREATENING RESPIRATORY DEPRESSION
Serious, life-threatening or fatal respiratory depression may occur
with the use of Morphine Sulfate
injection. Be aware of situations which increase the risk of
respiratory depression, modify dosing in
patients at risk and monitor patients closely, especially on
initiation or following a dose increase (see
section 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE).
CONCOMITANT
USE
OF
BENZODIAZEPINES
AND
OTHER
CENTRAL
NERVOUS
SYSTEM
(CNS)
DEPRESSANTS,
INCLUDING ALCOHOL
Concomitant use of opioids with other opioids analgesics,
benzodiazepines, gabapentinoids, sedatives,
hypnotics, antipsychotics, antihistamines, tricyclic antidepressants,
centrally-active anti-emetics, general
anaesthetics, tranquilisers, beta blocker, cannabis or other central
nervous system (CNS) depressants,
including alcohol, may result in profound sedation, respiratory
depression, coma, and death. Limit
dosages and durations to the minimum required; and monitor patients
for signs and symptoms of
respiratory depression and sedation. Caution patients not to drink
alcohol while taking Morphine Sulfate
injection (see section 4.4 SPECIAL WARNINGS